La Jolla Pharmaceutical Co (LJPC)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4550 TOWNE CENTRE COURT SAN DIEGO, CA 92121

La Jolla Pharmaceutical is a biopharmaceutical company focused on improving and preserving human life by developing enhanced pharmaceutical products. Co.'s key product in development is Riquent, which is designed to treat lupus renal disease by preventing or delaying renal flares, suppressing the production of antibodies to double-stranded deoxyribonucleic acid (dsDNA) in lupus patients without suppressing the normal function of the immune system. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues.

Data based on most recent fiscal year report
Market Cap672.696 Million Shares Outstanding22.15 Million Avg Volume769.239 Thousand
1-Yr BETA vs S&P TR Current Ratio5.07 Quick Ratio5.07
View SEC Filings from LJPC instead.
Q2 2019 All Institutions Hedge Funds 1
To trade LJPC now:
Filers who had this stock in their top 10: 4 1 (0.1%)
13F Filers holding this stock: 82 19 (1.96%)
Aggregate 13F shares on 06/30/2019: 27.327 Million 8.275 Million
Aggregate 13F shares on 03/31/2019: 25.418 Million 7.15 Million
Percent change: 7.51% 15.74%
Funds creating new positions: 20 5
Funds Adding to an existing position: 25 5
Funds closing out their position: 18 5
Funds reducing their position: 25 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LJPC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
10,802,467 2019-10-16 1

MULROY DENNIS CHIEF FINANCIAL OFFICER

  • Officer
4,223 2019-10-15 25

CHAWLA LAKHMIR S CHIEF MEDICAL OFFICER

  • Officer
6,498 2019-10-15 26

ROLKE JAMES CHIEF SCIENTIFIC OFFICER

  • Officer
79,336 2019-10-15 26

WELLINGHOFF DARRYL CHIEF COMMERCIAL OFFICER

  • Officer
2,950 2019-10-15 14

RAMSAY DAVID A

  • Director
0 2019-10-08 1

TANG KEVIN C

  • Director
5,821,098 2019-10-04 3

TOPPER JAMES N

  • Director
0 2019-09-30 0

TIDMARSH GEORGE F

  • Director
151,291 2019-09-19 15

ZARRABIAN SAIID PRESIDENT AND CEO

  • Officer
  • Director
0 2019-09-05 0

SUTTER MARTIN P

  • Director
188,939 2019-08-07 0

ADAMS THOMAS PHD

  • Director
0 2019-07-24 0

SMITH CRAIG R

  • Director
46,469 2019-04-18 0

CARVER JENNIFER CHIEF OPERATING OFFICER

  • Officer
14,049 2019-02-28 11

JOHNSON CRAIG A

0 2019-01-29 1

DOUGLASS LAURA L.

  • Director
0 2019-01-23 1

ROSEN ROBERT

  • Director
0 2019-01-23 1

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

  • Director
  • 10% Owner
4,938,893 2019-01-07 3

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
No longer subject to file 2018-11-27 0

FRAZIER HEALTHCARE V, LP

  • 10% Owner
No longer subject to file 2016-11-01 0

LIANG BERTRAND C. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-02-01 0

GILLESPIE DEIRDRE

  • Director
0 2016-01-04 0

FRAZIER HEALTHCARE V, LP

FHM V, LP

FHM V, LLC

  • 10% Owner
No longer subject to file 2013-09-24 0

BIOMARIN PHARMACEUTICAL INC

  • 10% Owner
6,666,667 2012-12-08 0

REINISCH RICHARD

  • INDIVIDUAL INVESTOR
1,100,000 2012-08-01 0

SLOAN GAIL A CHIEF FINANCIAL OFFICER

  • Officer
980 2011-04-20 0

FILDES ROBERT PHD

  • Director
0 2010-05-28 0

MARTIN STEPHEN

  • Director
0 2010-05-28 0

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

  • 10% Owner
2,371,642 2009-09-15 0

ELCHICO JOSEFINA T VP QUALITY OPERATIONS

  • Officer
0 2009-02-24 0

GONZALEZ ALEJANDRO

  • 10% Owner
No longer subject to file 2009-02-12 0

SEIKKULA LUKE VICE PRESIDENT MANUFACTURING

  • Officer
0 2009-01-22 0

TANSEY MICHAEL JAMES BYRON EXECUTIVE VP & CMO

  • Officer
0 2009-01-22 0

CAVIAR NIV EDWARD CHIEF BUSINESS OFFICER & CFO

  • Officer
0 2009-01-22 0

YOUNG FRANK

  • Director
0 2008-05-22 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-10-15 A 224 a 224 4,223.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-10-15 A 81 $7.12 a 6,498 6,498.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-10-15 A 112 a 112 79,336.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-10-15 A 224 $7.12 a 4,223 4,223.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-10-15 A 224 a 224 2,950.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-10-15 A 112 $7.12 a 79,336 79,336.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-10-15 A 81 a 81 6,498.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-10-15 A 224 $7.12 a 2,950 2,950.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-09-30 A 213 a 213 2,726.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-09-30 A 76 $7.48 a 6,417 6,417.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-09-30 A 107 a 107 79,224.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-09-30 A 213 $7.48 a 2,726 2,726.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-09-30 A 213 a 213 3,999.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-09-30 A 107 $7.48 a 79,224 79,224.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-09-30 A 76 a 76 6,417.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-09-30 A 213 $7.48 a 3,999 3,999.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-09-13 A 62 $9.28 a 6,341 6,341.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-09-13 A 171 a 171 3,786.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-09-13 A 85 $9.28 a 79,117 79,117.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-09-13 A 171 a 171 2,513.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-09-13 A 171 $9.28 a 3,786 3,786.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-09-13 A 62 a 62 6,341.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-09-13 A 171 $9.28 a 2,513 2,513.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-09-13 A 85 a 85 79,117.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-08-30 A 196 $8.13 a 2,342 2,342.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-08-30 A 98 a 98 79,032.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-08-30 A 70 $8.13 a 6,279 6,279.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-08-30 A 196 a 196 3,615.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2019-08-30 A 98 $8.13 a 79,032 79,032.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2019-08-30 A 196 a 196 2,342.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2019-08-30 A 196 $8.13 a 3,615 3,615.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2019-08-30 A 70 a 70 6,279.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments